Skip to main content

Latest stock market podcasts

From the helm: CSL's David Lamont on the biotech giant's bright future

Bell Direct
February 20, 2020

In the latest instalment of Bell Direct’s From the helm series, Jess has a chat with CSL’s CFO David Lamont. 

David gives the inside scoop on CSL, the market leader in the blood plasma and vaccine market. Additionally, he explains CSL’s own products, programmes and partnerships, and the steps taken by the medical giant to tackle coronavirus.

Plus, he sheds some light on the unique situation the broader pharmaceuticals industry finds itself in when it comes to new competition, as well as CSL’s future proofing strategy.

Morning Bell 14 March

Bell Direct
March 14, 2024

Morning Bell 13 March

Bell Direct
March 13, 2024

Morning Bell 12 March

Bell Direct
March 12, 2024

Morning Bell 11 March

Bell Direct
March 11, 2024

Weekly Wrap 8 March

Bell Direct
March 8, 2024

Morning Bell 8 March

Bell Direct
March 8, 2024

Morning Bell 7 March

Bell Direct
March 7, 2024

Morning Bell 6 March

Bell Direct
March 6, 2024

Morning Bell 5 March

Bell Direct
March 5, 2024

Morning Bell 4 March

Bell Direct
March 4, 2024

Weekly Wrap 1 March

Bell Direct
March 1, 2024

Morning Bell 1 March

Bell Direct
March 1, 2024